Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Siemens Unveils New Chemistry and Immunoassay Systems

Published: Thursday, July 31, 2014
Last Updated: Thursday, July 31, 2014
Bookmark and Share
Company introduces the ADVIA Chemistry XPT and ADVIA Centaur XPT Immunoassay System at AACC 2014.

Siemens Healthcare has introduced the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System at the 2014 AACC Annual Meeting and Clinical Lab Expo, Chicago, July 27-31.

The newest in the company’s portfolio of chemistry and immunoassay instruments for the central laboratory, these systems are designed to enable continuous and simple operation, facilitate delivery of high quality, rapid results, and work seamlessly with automation in high-volume laboratories.

“Faced with ever-increasing workload demands, our customers need easy-to-use solutions that enhance workflow and quickly provide the results,” said Franz Walt, CEO, Chemistry, Immunoassay, Automation and Diagnostics IT Business Unit, Diagnostics Division, Siemens Healthcare. “The ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System are new central laboratory analyzers designed to meet these requirements.”

Each system features versatile technology that will enable a broad range of testing to assist clinicians in disease screening, diagnosing and monitoring. Additionally, easy operation will be supported with harmonized, intuitive software, large touchscreens and Siemens Remote Service diagnostics.

A fast system for the high-volume laboratory with a throughput of up to 2400 tests per hour, the ADVIA Chemistry XPT System achieves predictable turnaround times through a combination of micro-volume technology and aliquot retention.

Sample aliquots are readily available onboard for testing and retesting; there is no need to return the tube to the system. The system also includes VeriSmart Technology, a combination of hardware and software checks to help ensure high-quality results.

The ADVIA Centaur XPT Immunoassay System is designed to process up to 240 tests per hour, upload test definitions on demand, and provide uninterrupted processing even when loading and unloading samples, reagents and supplies. The system is intended to require very little maintenance. Its user interface features powerful, easy-to-use software with extensive data management capabilities, and intelligent software algorithms are designed to support laboratory management of results by automatically providing effective diagnostic testing strategies.

Both systems are automation-ready, and can be connected to Siemens’ Aptio Automation, the company’s latest track-based automation system. They require no additional robotics, and utilize point-in-space technology which allows for sampling directly from the automation track.

Also, the ADVIA Chemistry XPT System and ADVIA Centaur XPT Immunoassay System can be connected to the company’s CentraLink Data Management System, which streamlines workflow across automation, IT and instruments, and Siemens Remote Service (SRS).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Criminal Justice Alcohol Program Linked to Decreased Mortality
Institute has announced that in the criminal justice alcohol program deaths dropped by 4.2 percent over six years.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Individuals' Medical Histories Predicted by their Noncoding Genomes
Researchers have found that analyzing mutations in regions of the genome that control genes can predict medical conditions such as hypertension, narcolepsy and heart problems.
'Molecular Movie' Opens Door to New Cancer Treatments
An international team of scientists led by the University of Liverpool has produced a 'structural movie' revealing the step-by-step creation of an important naturally occurring chemical in the body that plays a role in some cancers.
Advancing Synthetic Biology
Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.
Preparing for Potential Zika Outbreaks
Experts at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) are developing tools to monitor the spread of the Zika virus and are conducting research to gather more solid data to better assess the risks associated with the infection.
What do Banana Peels and Human Skin Have in Common?
Human skin and banana peels have something in common: they produce the same enzyme when attacked. By studying fruit, researchers have come up with an accurate method for diagnosing the stages of this form of skin cancer.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!